Biologics and Biosimilars: Federal Policies and Patient Access
Following the 1-hour program,
participants will be able to:
Recognize how federal policies relate to approval, naming and interchangeability.
Identify common barriers to patient access.
Expert presenters:
- Dennis Cryer, MD – Convener, Biologics Prescribers Collaborative
- Gavin Clingham, JD – Director of Public Policy, Alliance for Patient Access
- David Charles, MD – Founder, Alliance for Patient Access & co-covener, Biologics Prescribers Collaborative
Moderated By:
Dennis Cryer, MD – Convener, Biologics Prescribers Collaborative
